Financial Architects (New Jersey)’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-800
| Closed | -$265K | – | 326 |
|
|
2022
Q1 | $265K | Hold |
800
| – | – | 0.04% | 286 |
|
|
2021
Q4 | $287K | Hold |
800
| – | – | 0.04% | 275 |
|
|
2021
Q3 | $260K | Hold |
800
| – | – | 0.04% | 284 |
|
|
2021
Q2 | $250K | Hold |
800
| – | – | 0.04% | 301 |
|
|
2021
Q1 | $255K | Hold |
800
| – | – | 0.04% | 276 |
|
|
2020
Q4 | $259K | Hold |
800
| – | – | 0.05% | 246 |
|
|
2020
Q3 | $222K | Hold |
800
| – | – | 0.05% | 248 |
|
|
2020
Q2 | $193K | Hold |
800
| – | – | 0.04% | 246 |
|
|
2020
Q1 | $116K | Hold |
800
| – | – | 0.03% | 292 |
|
|
2019
Q4 | $136K | Hold |
800
| – | – | 0.03% | 289 |
|
|
2019
Q3 | $142K | Hold |
800
| – | – | 0.03% | 278 |
|
|
2019
Q2 | $208K | Sell |
800
-427
| -35% | -$113K | 0.04% | 244 |
|
|
2019
Q1 | $350K | Sell |
1,227
-203
| -14% | -$67.5K | 0.06% | 211 |
|
|
2018
Q4 | $464K | Sell |
1,430
-57
| -4% | -$19.8K | 0.09% | 150 |
|
|
2018
Q3 | $669K | Buy |
1,487
+20
| +1% | +$7.88K | 0.11% | 142 |
|
|
2018
Q2 | $600K | Sell |
1,467
-533
| -27% | -$193K | 0.11% | 140 |
|
|
2018
Q1 | $582K | Hold |
2,000
| – | – | 0.11% | 139 |
|
|
2017
Q4 | $375K | Hold |
2,000
| – | – | 0.06% | 200 |
|
|
2017
Q3 | $337K | Hold |
2,000
| – | – | 0.06% | 213 |
|
|
2017
Q2 | $287K | Hold |
2,000
| – | – | 0.05% | 237 |
|
|
2017
Q1 | $250K | Hold |
2,000
| – | – | 0.04% | 247 |
|
|
2016
Q4 | $225K | Hold |
2,000
| – | – | 0.05% | 232 |
|
|
2016
Q3 | $257K | Hold |
2,000
| – | – | 0.07% | 210 |
|
|
2016
Q2 | $219K | Hold |
2,000
| – | – | 0.06% | 229 |
|
|
2016
Q1 | $190K | Buy |
+2,000
| New | +$169K | 0.07% | 198 |
|
|
2015
Q3 | – | Sell |
-2,000
| Closed | -$131K | – | 993 |
|
|
2015
Q2 | $131K | Sell |
2,000
-2,000
| -50% | -$133K | 0.05% | 256 |
|
|
2015
Q1 | $286K | Hold |
4,000
| – | – | 0.11% | 146 |
|
|
2014
Q4 | $152K | Hold |
4,000
| – | – | 0.07% | 200 |
|
|
2014
Q3 | $99K | Hold |
4,000
| – | – | 0.05% | 224 |
|
|
2014
Q2 | $101K | Buy |
+4,000
| New | +$93.1K | 0.05% | 225 |
|
|
2013
Q4 | – | Sell |
-4,000
| Closed | -$76K | – | 601 |
|
|
2013
Q3 | $76K | Hold |
4,000
| – | – | 0.05% | 211 |
|
|
2013
Q2 | $86K | Buy |
+4,000
| New | +$80.4K | 0.06% | 180 |
|
Other funds holding ABMD
GIM
BCM
Financial Architects (New Jersey)'s ABMD Position: Q2 2022 in Review
Financial Architects (New Jersey) sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 800 shares — an estimated $265K sold.
Financial Architects (New Jersey) first reported a position in ABMD in Q2 2013 and held it in 32 quarters. The position peaked at $669K in Q3 2018. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.
- Financial Architects (New Jersey) reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
- Financial Architects (New Jersey) sold 800 Abiomed Inc shares in Q2 2022, an estimated $265K.
- Financial Architects (New Jersey) first reported a position in Abiomed Inc in Q2 2013 and held it in 32 quarters.
- Financial Architects (New Jersey)'s Abiomed Inc position peaked at $669K in Q3 2018.
- 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.
Based on Financial Architects (New Jersey)'s 13F filing for Q2 2022, filed 11 Aug 2022.